Here's hoping the pink wave washes the label of “women's issues” off the legislative agenda.
After nearly two decades of concerted efforts, it's time for the National Academies to judge whether quality and safety have improved and where new work is needed most.
Let's acknowledge that the CMS star-rating system spurs activities that raise costs without improving outcomes and begin rethinking the concept of quality measurement in healthcare.
Regarding the story "CMS actuary predicts GOP repeal bill will reduce coverage by 13 million" (ModernHealthcare.com, June 13), with the increasing number of plans that offer horrific coverage for care (catastrophic coverage designs, for example), it is somewhat unfair to simply state a lost coverage number.
Other populous states should take a close look at what California is doing. Smaller states may want to form compacts with their neighbors to pursue something similar. Gov. Gavin Newsom has offered a practical approach to achieving more reasonable drug pricing.
Dr. Rod Hochman in 2012 oversaw the union of Providence and a secular organization, Swedish Health Services. While acknowledging that every deal is different, Hochman says research is key to the sometimes scary move to combine organizations.